FindTrial
Sign In

NASAL DEXMEDETOMIDINE FOR SEDATION DURING ENDOSCOPIC RETROGRADE PANCREATOGRAPHY-A NOVEL ROUTE FOR NOT SO NOVEL DRUG

TO STUDY THE EFFECT OF PRETREATMENT WITH INTRANASAL DEXMEDETOMIDINE DURING PROCEDURAL SEDATION FOR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013308
Enrollment
90
Registered
2018-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- POSTED FOR ELECTIVE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY

Interventions

Intervention1: intranasal dexmedetomidine: to study the effect of intranasal dexmedetomidine on requirement of primary drugs like propofol and fentanyl for sedation during endoscopic retrograde cholan

Sponsors

MS RAMAIAH MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists Physical Status (ASAPS) Grade I, II and III.

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Patient refusal. 3. Patients with evidence of arrhythmias and Obstructive Sleep Apnoea. 4. Body Mass Index(BMI) >35kg/m2 5. Chronic sedative use. 6. Known psychiatric illness. 7. Allergy to any of the above mentioned drugs used in the study.

Design outcomes

Secondary

MeasureTime frame
to access the sedation score using OAA/S scaleTimepoint: post instillation every 15 minutes for 1 hour and post procedure evey 15 minutes for half an hour—

Primary

MeasureTime frame
to access the reduction in consumption of primary drugs at end of procedureTimepoint: time calculated from insertion of scope till its removal—

Countries

India

Contacts

Public ContactDR DARSHAN P

MS RAMAIAH MEDICAL COLLEGE AND HOSPITALS

nagarajmc58@gmail.com9972849779

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026